Maria Giuseppa Vitale
0000-0001-8551-266X
3 papers found
Refreshing results…
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)
Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report
Missing publications? Search for publications with a matching author name.